trending Market Intelligence /marketintelligence/en/news-insights/trending/e16nILuwe5LWD9BO_91K_A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Paine Schwartz invests in Warburton Technology

Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks

Paine Schwartz invests in Warburton Technology

Food and agribusiness-focused private equity firm Paine Schwartz Partners LLC created its animal health and nutrition investment platform following a strategic investment through its Paine Schwartz Food Chain Fund IV in Irish animal pharmaceuticals company Warburton Technology.

The platform will also include U.S.-based MS Biotech Holdings Inc., in which Paine Schwartz initially invested in October 2018.

Financial terms of the Warburton investment were undisclosed.

William Weldon was named CEO of the new platform. Weldon is an animal health industry veteran who served for more than 20 years at Elanco Animal Health.

Eithna O'Leary will remain as managing director of Warburton, while Leander van der Walt will remain CEO of MS Biotec, a provider of proprietary products for the beef feedlot and dairy markets.